
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Proteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics antibodies that target new biological mechanisms and are more potent, safer and longer lasting to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough...
Protein engineering,drug development,antibody drugs,biotechnology,oncology,autoimmune disease,bispecific antibodies,and cytokines
Xencor operates in the Biotechnology industry.
Xencor's revenue is 101m - 500m
Xencor has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.